NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new pill combo aims to boost lymphoma cure rates
⭐️ CURE ⭐️ Recruiting nowThis study tests whether adding the drug acalabrutinib to standard chemotherapy can cure more people with untreated diffuse large B-cell lymphoma, an aggressive blood cancer. About 132 adults will take the pill twice daily for up to 14 days, then receive standard chemo and rituxi…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️
Last updated May 17, 2026 05:06 UTC
-
New pill takes on Hard-to-Treat lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests an experimental tablet (HSK47977) in 110 adults whose Non-Hodgkin's lymphoma has returned or stopped responding to treatment. The main goals are to find the safest dose and check for side effects, while also looking at how well the drug works. Partici…
Matched conditions: NHL
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Yoga and mindfulness may boost well-being and even tweak genes in cancer survivors
Symptom relief Recruiting nowThis study looks at whether yoga and mindfulness can improve the social, emotional, and physical well-being of people who have had lung, colon, or non-Hodgkin's lymphoma cancer. Researchers will also check if these practices affect epigenetics—how our environment turns genes on o…
Matched conditions: NHL
Phase: NA • Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC